Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 4 of 4

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

VRDN-002, a Next-Generation Half-life Extended Antagonist Antibody to IGF-1 Receptor for Thyroid Eye Disease (TED): Safety and Pharmacokinetic/Pharmacodynamic (PK/PD) Results in Healthy Volunteers

Kelly Foster; Angela She; Rochelle M. Summerfelt; Brent Dickinson; Barrett Katz; Pawel Wiczling; Vahe Bedian

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4038.

ARVO Annual Meeting Abstract June 2023

Phase 1/2 Study of Treatment Response With VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor, in Patients with Thyroid Eye Disease (TED)

Roger Eric Turbin; Raymond Douglas; Shoaib Ugradar; Kimberly Cockerham; Jade Schiffman; Navdeep Nijhawan; Denis J. O'Shaughnessy; Rochelle M. Summerfelt; Angela She; Barrett Katz

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5432.

ARVO Annual Meeting Abstract April 2010

Involvement of SPARC and MMP-3 in the Migration of Conjunctival Epithelial Cells Upon Wounding

L. F. Seet; S. J. Yu; R. S. M. Su; T. T. Wong

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):1904.

ARVO Annual Meeting Abstract April 2009

Upregulation of SPARC Expression in Pterygium

L.-F. Seet; L. Tong; R. S. M. Su; T. T. Wong

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2619.

Advertisement